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Abstract Numerous studies suggest that proteasome inhibition
may play a causal role in mediating the increased levels of
protein oxidation and neuron death observed in conditions asso-
ciated with oxidative stress. In the present study we demonstrate
that administration of non-toxic levels of oxidative stress does
not result in impairment of 20S/26S proteasome activity, and
actually increases the expression of speci¢c proteasome sub-
units. Non-toxic levels of oxidative stress were observed to ele-
vate the amount of protein oxidation in the presence of pre-
served proteasomal function, suggesting that proteasome
inhibition may not mediate increases in protein oxidation follow-
ing low-level oxidative stress. Preserving basal proteasome func-
tion appears to be critical to preventing the neurotoxicity of
low-level oxidative stress, based on the ability of proteasome
inhibitor treatment to exacerbate oxidative stress toxicity. Tak-
en together, these data indicate that maintaining neural protea-
some function may be critical to preventing neurotoxicity, but
not the increase in protein oxidation, following low-level oxida-
tive stress.
& 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The proteasome is a large intracellular multicatalytic pro-
tease that is responsible for mediating the degradation of a
vast array of oxidized, misfolded, and aggregated proteins [1^
4]. The proteolytic core of the proteasome, referred to as the
20S proteasome, is composed of multiple K- and L-subunits
[5^8]. Additional cap-like protein complexes, referred to as the
11S and 19S proteasomes, can bind to the 20S proteasome
resulting in the formation of the 26S proteasome [5^8].
Increasing evidence suggests that the activity and composi-
tion of the proteasome can be altered in immune cells in
response to in£ammatory stimuli [9,10]. The functional impor-
tance of such changes is highlighted by studies in transgenic
mice that have demonstrated that the ability to alter protea-
some homeostasis in these immune cells is essential to main-
taining proper immune function [11^14]. Despite the tremen-
dous progress that has been made in understanding
proteasome biology in the immune system, the role of the
proteasome in other systems, such as the nervous system, is
only beginning to be elucidated.
Numerous studies indicate that oxidative stress occurs in a
number of neurodegenerative conditions, and may play a
causal role in the neurodegeneration observed in those con-
ditions [15^25]. Recent studies have also indicated a possible
causal role for proteasome inhibition in the neurotoxicity as-
sociated with oxidative stress [22]. Pharmacological inhibition
of the proteasome is su⁄cient to induce neural death [26^31],
consistent with proteasome inhibition playing a causal role in
the neurodegeneration observed in conditions such as Alz-
heimer’s disease (AD) and Parkinson’s disease (PD). How-
ever, at present the role of the proteasome in preventing or
promoting the elevations in protein oxidation and neuron
death following low-level oxidative stress has not been eluci-
dated.
2. Materials and methods
2.1. Materials
Proteasome substrates were purchased from Bachem, the protein
oxidation kit from Intergen, and all reverse transcription polymerase
chain reaction (RT-PCR) supplies from Invitrogen. All cell culture
media and serum were obtained from Gibco Life Sciences. The pro-
teasome antibodies were purchased from A⁄nity Bioreagents Incor-
porated. All remaining chemicals and reagents were purchased from
Sigma Chemical.
2.2. Establishment of primary rat cortical neurons and
maintenance of neural cell lines
Primary cortical neurons were established and maintained from E18
Sprague^Dawley rats as described previously [27]. Neural SH-SY5Y
cells were purchased from the American Tissue Culture Collection,
and grown in minimum essential medium containing 10% heat-inacti-
vated fetal bovine serum and 1% penicillin/streptomycin. Cells were
maintained in 5% CO2 in a 37‡C incubator, with cells of fewer than 20
passages utilized for all studies.
2.3. Analysis of cell survival
Cell viability was determined by 3-[4,5-dimethylthiazol-2-yl]-2,5-di-
phenyltetrazolium bromide (MTT) conversion as described previously
[26,32^34]. At least eight cultures were utilized for each time point.
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Results from MTT assays were con¢rmed using Hoechst 33258 stain-
ing as described previously [32^34]. Cell survival in primary neurons
was determined as described previously [27], utilizing repeated visual
cell counts in the same microscopic ¢eld, with cell counts made before
and after treatment utilized for determining the percentage of neuron
death.
2.4. Analysis of proteasome activity
Proteasome activity was determined as described previously [26,33].
Brie£y, cell lysates were collected and protein aliquots (1 Wg/Wl) gen-
erated in proteasome activity bu¡er (10 mmol/l Tris^HCl (pH 7.8),
1 mmol/l EDTA, 0.5 mmol/l dithiothreitol, and 5 mmol/l MgCl2). The
activity of the 20S and 26S proteasome was distinguished by the
absence or inclusion of 2 mmol/l ATP, as described previously
[2,35]. Chymotrypsin-like and post-glutamyl peptidase activities of
the proteasome were determined by measuring the rate of Suc-Leu-
Leu-Val-Tyr-MCA and Suc-Leu-Leu-Glu-MCA, respectively. Fluo-
rescence was monitored at 340 nm excitation and 440 nm emission.
2.5. Analysis of protein oxidation
The levels of protein oxidation were determined by dot blot analysis
using an oxidized protein detection kit as described previously [36,37].
This assay is based on the immunochemical detection of protein car-
bonyl groups derivatized with 2,4-dinitrophenyl hydrazine, according
to the manufacturer’s instructions. All samples were performed in
duplicate.
2.6. Analysis of proteasome expression
For real-time RT-PCR analysis of proteasome subunit expression
total RNA was collected from cells at the times indicated as described
previously [33,38]. For each reaction a total of 150 ng of total RNA
was ampli¢ed according to the manufacturer’s instructions using
SYBR0 Green PCR Master Mix reagent, as described previously
[39]. The following parameters were utilized: LMP2: 30 min at
48‡C, 5 min at 95‡C, 30 s at 94‡C, 30 s at 56‡C, 50 s at 72‡C;
LMP7: 30 min at 48‡C, 5 min at 95‡C, 30 s at 94‡C, 30 s at 52‡C,
50 s at 72‡C; LMP10: 30 min at 48‡C, 5 min at 95‡C, 30 s at 94‡C,
30 s at 57‡C, 50 s at 72‡C; PRE4: 30 min at 48‡C, 5 min at 95‡C, 30 s
at 94‡C, 30 s at 56‡C, 50 s at 72‡C; 18S: 30 min at 48‡C, 5 min at
95‡C, 30 s at 94‡C, 30 s at 48‡C, 50 s at 72‡C. LMP2, LMP7, LMP10,
PRE4, and 18S were ampli¢ed for 26, 26, 18, 12, and 9 cycles respec-
tively. Primers used for ampli¢cation were as follows: LMP2: 5P-GAT
GCT GCG GGC GGG AGC ACC ACC-3P, 3P-CAG TTC ATT
GCC CAA GAT GAC TC-5P (640 bp); LMP7: 5P-CTG CTT GGC
ACC ATG TCT GGC TG-3P, 3P-TCT ACT TTC ACC CAA CCA
TCT TC-5P (443 bp); LMP10: 5P-ATC CTG GGC GGC GTA GAC
CTG AC-3P, 3P-TTA CTC CAC CTC CAT AGC CTG CAC-5P (411
bp); PRE4, 5P-TGG CTC GTT TCC GCA ACA TCT CTC-3P, 3P-
GGT CTG TGT AGA CAA TGG TCC CTC-5P (524 bp); 18S, 5P-
GAC AGG ATT GAC AGA TTG ATA G-3P, 3P-CAC TTG TCC
CTC TAA GAA GTT G-5P (174 bp). Following ampli¢cation one
major band was detected by gel electrophoresis, with all ampli¢cations
adhering to the SYBR0 Green dissociation protocol. Data were col-
lected and analyzed using ABI Prism 20000. Proteasome subunit ex-
pression at the protein level was conducted by Western blot analysis,
as described previously from our laboratory [26,27]. Data are repre-
sentative of results from at least four separate experiments.
2.7. Statistical analysis
Statistical signi¢cance was determined using Student’s t-test, with a
P value of 6 0.05 required for signi¢cance.
3. Results
3.1. Relationship between neural proteasome activity,
protein oxidation, and neural viability
In order to determine the relationship between oxidative
stress-induced alterations in neural viability, proteasome func-
tion, and protein oxidation we conducted studies in human
neural SH-SY5Y cells. Following exposure to increasing con-
centrations of H2O2 cells were analyzed for cellular viability
by quanti¢cation of MTT reduction and analysis of nuclear
morphology. Administration of H2O2 caused a dose- and
time-dependent induction of neural death, with addition of
50 WM H2O2 signi¢cantly increasing neural death at both 8 h
and 24 h post administration (Fig. 1A,B). Analysis of pro-
tein oxidation in this experimental paradigm revealed that
each of the concentrations of H2O2 utilized for survival stud-
ies caused an elevation in the levels of protein oxidation as
early as 3 h following treatment (Fig. 1C). Analysis of 20S
and 26S proteasome activity revealed that no signi¢cant alter-
ation in either 20S or 26S proteasome activity was evident 3 h
following oxidative stress treatment (Fig. 1D), with 1^10 WM
H2O2 inducing small elevations in 20S proteasome activity in
several experiments (data not shown). Addition of toxic con-
centrations of H2O2 (50 WM) was observed to inhibit both 20S
and 26S chymotrypsin-like proteasome activity following a
24 h incubation (Fig. 1E). Identical results were obtained
with analysis of 20S and 26S post-glutamyl peptidase activity
of the proteasome (data not shown).
3.2. Oxidative stress increases the expression of
multiple proteasome subunits
In order to elucidate the e¡ect of oxidative stress on pro-
teasome subunit expression, we analyzed the expression of
multiple proteasome subunits following the addition of 10
WM H2O2. At the protein level increased levels of the induc-
ible proteasome subunits LMP2, LMP7, and LMP10 were
observed following H2O2 treatment (Fig. 2). No elevation in
L-tubulin expression was observed following administration of
oxidative stress (Fig. 2), con¢rming that elevations in protea-
some subunit expression were not an artifact of oxidative
stress treatment. Real-time RT-PCR revealed that elevated
levels of LMP2 and LMP10 mRNA were evident following
treatment with 10 WM H2O2 (Fig. 3A). Additionally, expres-
sion of the proteasome subunit PRE4, a subunit responsible
for post-glutamyl peptidase activity, was elevated following
treatment with 10 WM H2O2 (Fig. 3A). No alteration in 18S
rRNA was observed following oxidative stress treatment (Fig.
3A). Electrophoresis of RT-PCR products revealed that only
one major product was generated by RT-PCR reaction (Fig.
3B).
3.3. Proteasome activity is necessary to prevent the toxicity of
low-level oxidative stress
Analysis of proteasome activity and proteasome expression
following low-level oxidative injury suggested that neural pro-
teasome biology was dramatically altered, and may play a role
in preventing neural death following exposure to oxidative
injury. In order to directly determine if maintenance of pro-
teasome activity played a causal role in preventing oxidative
stress-induced neurotoxicity, we conducted studies in which
neural SH-SY5Y cells were co-administered amounts of
H2O2 and proteasome inhibitor that did not induce neuro-
toxicity when administered individually. Co-administration
of sub-lethal levels of H2O2 and proteasome inhibitor was
su⁄cient to induce signi¢cant levels of neural cell death in
SH-SY5Y cells (Fig. 4A). Similar results were obtained in
primary rat cortical neurons co-administered sub-lethal levels
of H2O2 and MG115 (Fig. 4B).
4. Discussion
Data from the present study indicate that neural 20S pro-
teasome and neural 26S proteasome activity is not inhibited
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following exposure to low-level oxidative stress. Such data
indicate that neural proteasome activity may not necessarily
be as vulnerable to oxidative stress-induced inhibition as pre-
viously anticipated. In future studies it will be important to
determine if aging a¡ects the ability of neural cells to maintain
proteasome activity following low-level oxidative stress. At
present it is unclear whether proteasome inhibition is respon-
sible for causing elevations in oxidative stress within the brain,
or whether oxidative stress may be responsible for mediating
proteasome inhibition in the brain. In the present study, ad-
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Fig. 1. Oxidative stress alters neural viability, protein oxidation, and proteasome function. Neural SH-SY5Y cells were exposed to increasing
concentrations of H2O2 and analyzed for cell death using either MTT reduction (A) or nuclear morphology (B) as an index of neural survival.
MTT reduction was analyzed 8 and 24 h post treatment, with nuclear morphology analyzed 24 h post treatment. Protein carbonyl formation
was analyzed in neural SH-SY5Y cells exposed to increasing concentrations of H2O2 (C), at 3 or 24 h post administration. Neural SH-SY5Y
cells were analyzed for 20S (3ATP) or 26S (+ATP) proteasome activity 3 h (D) or 24 h (E) following the administration of increasing concen-
trations of H2O2. Data presented are the mean and S.E.M. of at least six samples from at least two separate experiments. *P6 0.05 compared
to control cultures; **P6 0.05 compared to cultures treated for 3 h.
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ministration of mild oxidative stress (1 and 10 WM H2O2) was
observed to elevate the amount of protein oxidation within
neural cells in the absence of detectable levels of proteasome
inhibition. These data suggest that proteasome inhibition may
not necessarily be a mediator of increased protein oxidation
following low-level oxidative stress.
Studies in this paper demonstrate for the ¢rst time the abil-
ity of the neural proteasome to undergo dramatic and selec-
tive alterations in proteasome subunit expression following
the administration of oxidative stress. Previous studies from
our laboratory have demonstrated that the expression of ag-
gregate-prone proteins (polyglutamine-containing proteins)
chronically increases the expression of LMP2 expression in
neural cells [33], suggesting that increases in LMP2 expression
may be a mechanism that neural cells utilize to survive in the
presence of aggregate-prone proteins. In that same study, neu-
ral cells expressing elevated levels of LMP2 under basal con-
ditions were unable to elevate proteasome activity in response
to heat shock stress [33], suggesting that chronic expression of
inducible proteasome subunits may adversely a¡ect the ability
of the neural proteasome to respond to subsequent stress.
Such data strongly suggest that the expression of individual
proteasome subunits is essential to the preservation of neural
proteasome function and neuronal viability. It is likely that
aging a¡ects the ability of neural cells to increase proteasome
subunit expression following a variety of stressors [40], as
such an attenuation in proteasome plasticity may directly con-
tribute to age-related inhibition of proteasome activity.
In the present study, neural 20S and 26S proteasome activ-
ity were decreased to a similar degree by administration of
lethal oxidative injury. Because the observed decrease in pro-
teasome activity did not occur within the ¢rst 3 h of oxidative
injury, and occurred to a similar degree as the amount of
neural death, these data suggest that the observed decreases
in proteasome activity following oxidative injury may be due
in a large part to a decrease in the number of viable neural
cells. Such an observation may be particularly important in
neurodegenerative conditions that are associated with the
presence of decreased proteasome activity and elevated levels
of oxidative stress. For example, at present it is unclear
whether the loss of proteasome activity in neurodegenerative
disorders such as AD and PD are due to the inhibition of
proteasome activity in neural cells, or whether loss of protea-
some activity is an artifact of increased levels of neural death
observed in those conditions. It is interesting to point out that
the studies describing impairments of proteasome activity in
AD and PD report only seeing a loss of proteasome activity in
the brain regions exhibiting the largest amount of neuron
death, and report impairments in multiple proteasome proteo-
Fig. 2. Oxidative stress alters the expression of proteasome subunits
at the protein level. At the times indicated, proteins were collected
from neural SH-SY5Y cells treated with 10 WM H2O2. Equal
amounts of cellular lysates (50 Wg) were then separated by electro-
phoresis, transferred to a nitrocellulose membrane, and immuno-
reacted with the indicated antibody. Data are representative of re-
sults from at least two experiments.
Fig. 3. Oxidative stress alters the expression of proteasome subunits
at the mRNA level. A: Neural SH-SY5Y cells were analyzed via
real-time RT-PCR analysis for the amount of LMP2, LMP7,
LMP10, PRE4, or 18S rRNA expression following the administra-
tion of 10 WM H2O2. B: Analysis of RT-PCR products revealed
that only one major band was generated following the RT-PCR
procedure. Samples were collected at the times indicated and equal
amounts of mRNA subject to real-time RT-PCR. Data are ex-
pressed as the mean and S.E.M. of results from two separate experi-
ments.
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lytic activities, with both the 20S and 26S proteasome activ-
ities inhibited [23^25].
Cumulatively, data from the present study indicate the im-
portance of identifying proteasome inhibition in AD and PD,
but also developing an understanding of how proteasome bi-
ology changes in each of these disorders. In particular it is
critical to develop a better understanding of the e¡ects of
normal aging on the dynamics of neural proteasome activity,
proteasome expression, and proteasome composition within
the brain.
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Fig. 4. Pharmacological inhibition of proteasome activity exacer-
bates the toxicity of oxidative stress. Neural SH-SY5Y cells (A) or
primary rat cortical neurons (B) were co-treated with non-toxic con-
centrations of H2O2 (1 WM) and non-toxic concentrations of
MG115 (0.1 or 0.01 WM) and analyzed for cellular viability 24 h
following treatment. Data presented are the mean and S.E.M. of at
least six samples from at least two separate experiments. *P6 0.05
compared to control cultures.
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